Bakytzhan Bakhautdin1, Dola Das1, Palash Mandal1, Sanjoy Roychowdhury1, Jazmine Danner1, Katelyn Bush1, Katherine Pollard1, James W Kaspar1, Wei Li2, Robert G Salomon2, Megan R McMullen1, Laura E Nagy3. 1. Center for Liver Disease Research, Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States. 2. Department of Chemistry, Case Western Reserve University, Cleveland, OH, United States. 3. Center for Liver Disease Research, Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States; Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH, United States. Electronic address: nagyL3@ccf.org.
Abstract
BACKGROUND & AIMS: Alcoholic liver disease is associated with inflammation and cell death. Heme oxygenase-1 (HO-1) is a stress-inducible enzyme with anti-apoptotic and anti-inflammatory properties. Here we tested the hypothesis that induction of HO-1 or treatment with a carbon monoxide releasing molecule (CORM) during chronic ethanol exposure protects and/or reverses ethanol-induced liver injury. METHODS: Female C57BL/6J mice were allowed free access to a complete liquid diet containing ethanol or to pair-fed control diets for 25days. Mice were treated with cobalt protoporphyrin (CoPP) to induce HO-1 expression during ethanol feeding or once liver injury had been established. Mice were also treated with CORM-A1, a CO-releasing molecule (CORM), after ethanol-induced liver injury was established. The impact of HO-1 induction on ethanol-induced cell death was investigated in primary cultures of hepatocytes. RESULTS: Induction of HO-1 during or after ethanol feeding, as well as treatment with CORM-A1, ameliorated ethanol-induced increases in AST and expression of mRNAs for inflammatory cytokines. Treatment with CoPP or CORM-A1 also reduced hepatocyte cell death, indicated by decreased accumulation of CK18 cleavage products and reduced RIP3 expression in hepatocytes. Exposure of primary hepatocyte cultures to ethanol increased their sensitivity to TNFα-induced cell death; this response was attenuated by necrostatin-1, an inhibitor of necroptosis, but not by caspase inhibitors. Induction of HO-1 with CoPP or CORM-3 treatment normalized the sensitivity of hepatocytes to TNFα-induced cell death after ethanol exposure. CONCLUSIONS: Therapeutic strategies to increase HO-1 and/or modulate CO availability ameliorated chronic ethanol-induced liver injury in mice, at least in part by decreasing hepatocellular death.
BACKGROUND & AIMS:Alcoholic liver disease is associated with inflammation and cell death. Heme oxygenase-1 (HO-1) is a stress-inducible enzyme with anti-apoptotic and anti-inflammatory properties. Here we tested the hypothesis that induction of HO-1 or treatment with a carbon monoxide releasing molecule (CORM) during chronic ethanol exposure protects and/or reverses ethanol-induced liver injury. METHODS: Female C57BL/6J mice were allowed free access to a complete liquid diet containing ethanol or to pair-fed control diets for 25days. Mice were treated with cobalt protoporphyrin (CoPP) to induce HO-1 expression during ethanol feeding or once liver injury had been established. Mice were also treated with CORM-A1, a CO-releasing molecule (CORM), after ethanol-induced liver injury was established. The impact of HO-1 induction on ethanol-induced cell death was investigated in primary cultures of hepatocytes. RESULTS: Induction of HO-1 during or after ethanol feeding, as well as treatment with CORM-A1, ameliorated ethanol-induced increases in AST and expression of mRNAs for inflammatory cytokines. Treatment with CoPP or CORM-A1 also reduced hepatocyte cell death, indicated by decreased accumulation of CK18 cleavage products and reduced RIP3 expression in hepatocytes. Exposure of primary hepatocyte cultures to ethanol increased their sensitivity to TNFα-induced cell death; this response was attenuated by necrostatin-1, an inhibitor of necroptosis, but not by caspase inhibitors. Induction of HO-1 with CoPP or CORM-3 treatment normalized the sensitivity of hepatocytes to TNFα-induced cell death after ethanol exposure. CONCLUSIONS: Therapeutic strategies to increase HO-1 and/or modulate CO availability ameliorated chronic ethanol-induced liver injury in mice, at least in part by decreasing hepatocellular death.
Authors: Kaori Kuramitsu; David Gallo; Myunghee Yoon; Beek Y Chin; Eva Csizmadia; Douglas W Hanto; Leo E Otterbein Journal: Hepatology Date: 2011-06 Impact factor: 17.425
Authors: Joseph C Onyiah; Shehzad Z Sheikh; Nitsan Maharshak; Erin C Steinbach; Steven M Russo; Taku Kobayashi; Lantz C Mackey; Jonathan J Hansen; Adam J Moeser; John F Rawls; Luke B Borst; Leo E Otterbein; Scott E Plevy Journal: Gastroenterology Date: 2012-12-22 Impact factor: 22.682
Authors: D Vercammen; G Brouckaert; G Denecker; M Van de Craen; W Declercq; W Fiers; P Vandenabeele Journal: J Exp Med Date: 1998-09-07 Impact factor: 14.307
Authors: Dian J Chiang; Sanjoy Roychowdhury; Katelyn Bush; Megan R McMullen; Sorana Pisano; Kathryn Niese; Mitchell A Olman; Michele T Pritchard; Laura E Nagy Journal: PLoS One Date: 2013-07-18 Impact factor: 3.240
Authors: George S Drummond; Jeffrey Baum; Menachem Greenberg; David Lewis; Nader G Abraham Journal: Arch Biochem Biophys Date: 2019-08-16 Impact factor: 4.013
Authors: Hao Zhou; Minjia Yu; Junjie Zhao; Bradley N Martin; Sanjoy Roychowdhury; Megan R McMullen; Emily Wang; Paul L Fox; Sho Yamasaki; Laura E Nagy; Xiaoxia Li Journal: Hepatology Date: 2016-10-25 Impact factor: 17.425